Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard G Birnbaum

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Journal of Occupational and Environmental Medicine|January 12, 2008
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work lossLeigh Ann White, Howard G Birnbaum, Anna Kaltenboeck, et al.
Pharmacoeconomics|July 31, 2009
Determinants of direct cost differences among US employees with major depressive disorders using antidepressantsHoward G Birnbaum, Rym Ben-Hamadi, Paul E Greenberg, et al.
Journal of Medical Economics|January 24, 2013
Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritisNoam Y Kirson, Sumati Rao, Howard G Birnbaum, et al.
Annals of the American Thoracic Society|February 3, 2015
Impact of a telehealth and care management program for patients with chronic obstructive pulmonary diseaseDavid H Au, Dendy S Macaulay, John L Jarvis, et al.
Current Medical Research and Opinion|July 29, 2011
Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United StatesNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
Chemotherapy Research and Practice|April 7, 2012
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancerCrystal T Pike, Howard G Birnbaum, Catherine E Muehlenbein, et al.
Journal of Opioid Management|May 20, 2015
Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costsAlan G White, Joseph LeCates, Howard G Birnbaum, et al.
Journal of Opioid Management|December 20, 2013
The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer painJasmina I Ivanova, Howard G Birnbaum, Yana Yushkina, et al.
The Journal of Heart Valve Disease|August 19, 2007
Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?David S Bach, Jasmina I Radeva, Howard G Birnbaum, et al.
Annals of Vascular Surgery|June 29, 2010
Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial diseaseMichael R Jaff, Kevin E Cahill, Andrew P Yu, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Journal of Occupational and Environmental Medicine|January 12, 2008
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work lossLeigh Ann White, Howard G Birnbaum, Anna Kaltenboeck, et al.
Pharmacoeconomics|July 31, 2009
Determinants of direct cost differences among US employees with major depressive disorders using antidepressantsHoward G Birnbaum, Rym Ben-Hamadi, Paul E Greenberg, et al.
Journal of Medical Economics|January 24, 2013
Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritisNoam Y Kirson, Sumati Rao, Howard G Birnbaum, et al.
Annals of the American Thoracic Society|February 3, 2015
Impact of a telehealth and care management program for patients with chronic obstructive pulmonary diseaseDavid H Au, Dendy S Macaulay, John L Jarvis, et al.
Current Medical Research and Opinion|July 29, 2011
Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United StatesNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
Chemotherapy Research and Practice|April 7, 2012
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancerCrystal T Pike, Howard G Birnbaum, Catherine E Muehlenbein, et al.
Journal of Opioid Management|May 20, 2015
Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costsAlan G White, Joseph LeCates, Howard G Birnbaum, et al.
Journal of Opioid Management|December 20, 2013
The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer painJasmina I Ivanova, Howard G Birnbaum, Yana Yushkina, et al.
The Journal of Heart Valve Disease|August 19, 2007
Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?David S Bach, Jasmina I Radeva, Howard G Birnbaum, et al.
Annals of Vascular Surgery|June 29, 2010
Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial diseaseMichael R Jaff, Kevin E Cahill, Andrew P Yu, et al.
Pageof 12